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1. Introduction 
The basic pancreatic trypsin inhibitor (BPTI) in- 
hibits a number of alkaline proteases. The most stable 
complex which the inhibitor forms is that with trypsin. 
The dissociation constant of this complex at pH 7.8 
is 2 X lo-lo [ 11. The complex of BPTI with chymo- 
trypsin is far less stable [2]. Green [l] has shown that 
the binding affinity of BPTI for active trypsin is not 
affected by the presence of a 30-fold excess of DIP- 
trypsin (di-isopropylphosphoryltrypsin) and that a 
specific interaction between DIP-trypsin and BPTI is 
not detectable by sedimentation analysis. 
In this study an effort was made to determine by 
the method of gel Mtration on Sephadex G-50 the 
binding affinity of trypsinogen, DIP-trypsin, chymo- 
trypsinogen and DIP-chymotrypsin for BPTI. The 
formation of the complex was observed only in the 
case of trypsinogen. 
2. Materials and Methods 
Trypsinogen was obtained from beef pancreas ac- 
cording to Balls [3] and was twice recrystallized. DIP- 
derivatives of trypsin and o-chymotrypsin were ob- 
tained from commercial crystalline products (Leeiva, 
Prague) by the reaction with di-isopropylphospho- 
fluoridate [4] and were twice recrystallized. Chymo 
trypsinogen (LeCiva, Prague) was crystallized seven 
times with ammonium sulfate and twice with ethanol 
[5]. BPTI was prepared by the method of Dlouha et 
al. [6]. 
Preparation of complexes. The zymogen or the in- 
hibited enzyme (12 mg) was dissolved in 0.5 ml of 
O.OlM (NH,),CO, at pH 8.6 and 12 mg of BPTI dis- 
solved in an equal volume of the same buffer was ad- 
ded. The reaction mixture was set aside for 15 min at 
25” and then passed through a Sephadex G-50 column 
under the conditions given in the legend to fig. 1. The 
course of the separation was examined spectrophoto 
metrically and by testing the inhibitory activity of ali- 
quots of individual fractions. 
The activity of BPTI was assayed by a modifica- 
tion of the method of Nagel et al. [7] and the inhibi- 
tion of tryptic hydrolysis of benzoyl-arginine-p- 
nitranilide hydrochloride (BAPA) by BPTI was deter- 
mined. A 100 ~1 aliquot of each fraction was with- 
drawn, mixed with 100 pl of 5% trichloroacetic acid 
and allowed to stand 5 min. To this mixture, 2.5 ml 
of buffer (0.1 M Tris HCl - 0.02M CaCl,, pH 7.8) 
and 100 pl of a trypsin solution containing 40 pg of 
the enzyme in O.OOlM HCl - 0.02M CaCl2 were ad- 
ded. After 5 min of incubation at 24”, 1.2 mg of 
BAPA in 100 pl of formamide was added. The reac- 
tion mixture was incubated 10 mm at 37”) acidified 
with 0.5 ml of 30% acetic acid, and its absorbance at 
405 nm determined. The inhibitory activity was ex- 
pressed as the difference in tryptic activity of the 
standard and of the assayed fraction. These values 
were expressed in c(g of inhibited trypsin with the aid 
of a calibration curve for the standard. 
N-terminal amino acids were determined by the 
method of Sanger [8] after 16-hour hydrolysis of the 
derivative. 
3. Results 
As is apparent from fig. lA, the inhibitory activi- 
ty after the interaction of a molar excess of BPTI 
with trypsinogen was found both in fractions corres- 
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Fig. 1. Gel filtration of the mixture of BPTI and the zymogens (or inhibited enzymes) on Sephadex G-50. Molar zymogen (en- 
zyme) to inhibitor ratio 1: 4. The 49 X 1.6 cm column was eluted with O.OlM (NH&COs, pH 8.6 at a rate of 12 ml per hour. 
- absorbance at 280 nm; ------- inhibitory activity in fig of trypsin. Elution profiles obtained with mixtures of BPTI and A, 
trypsinogen; B, DIP-trypsin; C, chymotrypsinogen; D, DIP-chymotrypsin. 
ponding to the high molecular weight component, i.e. 
to trypsinogen, and also in the peak representing the 
excess of free inhibitor. The ammo acid composition 
of the product obtained after lyophilization of the 
material contained in the first peak (fig. 1A) is given in 
table 1. This data leads us to conclude that the tryp 
sinogen to BPTI ratio in the complex is 1: 1. 
When the complex of trypsinogen with BPTI was 
subjected to qualitative N-terminal end-groups anal- 
ysis, evidence was found of valine (N-terminal group 
of trypsinogen) and of arginine (N-terminal group of 
BPTI), in addition to traces of serine. 
By contrast, in all the remaining preparations 
examined (as obvious from fig. lB, C and D) the first 
peak corresponds to free DIP-trypsin, chymotrypsi- 
nogen, and DIP-chymotrypsin, respectively, while the 
inhibitory activity is shown exclusively in the second 
peak. In every case, in the maximum of the second 
peak there are fractions in which the total amount of 
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trypsin added was completely inhibited (i.e. the upper 
limit of the sensitivity of the method was reached). 
On purpose the range of amount of trypsin added 
was chosen so that total absence of BPTI in the first 
peak in B-D be shown. Hence, these proteins do not 
react with the inhibitor. 
4. Discussion 
The investigation of the interaction of BPTI with 
trypsinogen has shown that there is a specific interac- 
tion between the two components, the molar ratio 
being 1: 1. This observation cannot be accounted for 
by non-specif= adsorption or incomplete fractiona- 
tion of the reaction mixture since the excess of BPTI 
would have separated chromatographically (fig. 1A). 
If this phenomenon were to be attributed to adsorp 
tion we should meet with the same effect also in the 
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Table 1 
Amino acid composition of trypsinogen (TG), BPTI and of their complex. 
Amino acid BPTI TG Theory for TG:BPTI ratio 
1:2 1: 1 
Analytical values 
for TGBPTI com- 
plex (peak 1, fii. 
IA) 
LYS 4 15 23 19 20.4 
His 0 3 3 3 3.4 
Arg 6 2 14 8 1.5 
Asp 5 26 36 31 32.0 
Thr 3 10 16 13 12.4 
Ser 1 34 36 35 33.6 
Glu 3 14 20 17 17.3 
FYO 4 8 16 12 13.0 
Gly 6 25 37 31 31.2 
Ala 6 14 26 20 19.5 
r/2 cys 6 12 24 18 12.1 
Val 1 18 20 19 16.5 
Met 1 2 4 3 3.2 
Ile 2 15 19 17 15.0 
Leu 2 14 18 16 16.0 
Tyr 4 10 18 14 13.2 
Phe 4 3 11 I 6.4 
Trp 0 4 4 4 
Samples after 24 hour hydrolysis were analyzed. Values are as moles of amino acid. For the calculation of the number of amino 
acid residues (last column), the average value of leucine was taken to represent 16.0 residues (assuming a 1: 1 TG : BPTI ratio). 
The lower values for valine and isoleucine are due to the presence of bonds Ile.Ile in BPTI and Ile.Val in trypsin, which are very 
resistant o hydrolysis. The tryptophan content of the complex was not determined. 
case of DIP-trypsin, chymotrypsinogen, and DIP- 
chymotrypsin, whose molecular weights and primary 
structures are very similar. In the case of DIP-trypsin 
the lack of ability to form a complex with BPTI has 
been shown by Green [ 11. The mode of interaction 
between trypsinogen and BPTI is therefore bonding be- 
tween specific residues. The inhibitory activity assays 
clearly show, however, that the addition of trypsin 
results in the liberation of the inhibitor from the 
complex with trypsinogen, and that the inhibitor then 
inhibits the active enzyme. The binding affinity of 
trypsin for BPTI is therefore greater than the binding 
affinity of trypsinogen. 
The binding of the inhibitor by trypsinogen, which 
is not an active enzyme, can be ascribed to the ana- 
logous three-dimensional arrangement of amino acid 
residues of the binding site of the zymogen and the 
enzyme. At the same time, the difference in the struc- 
ture of trypsin and trypsinogen is more pronounced 
than the difference in the structure of trypsin and 
DIP-trypsin. During the process of zymogen activation 
the N-terminal hexapeptide Val.Asp, .Lys is split off. 
A salt bridge is then formed between the N-terminal 
isoleucine and the aspartic acid residue no. 182, a 
structural rearrangement analogous to that observed 
in chymotrypsin [9]. By contrast, the conforma- 
tional change which parallels the trypsin into DIP- 
trypsin conversion most likely involves only the imme- 
diate environment of the active site, i.e. of the substi- 
tuted serine residue no. 183. In chymotrypsinogen, 
as in trypsinogen, the active serine residue is free. 
Both enzymes show considerable similarity in their 
structures. Nevertheless, neither chymotrypsinogen 
nor DIP-chymotrypsin reacts with BPTI. 
It is known that the bond between BPTI and 
chymotrypsin is less stable than the bond between 
BPTI and trypsin [2]. So far we are lacking evidence 
that the combination of the inhibitor with chymo- 
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trypsin is due to the same amino acid residue in the References 
April 1969 
inhibitor molecule, i.e. to Lys no. 15, which has been 
shown to interact with trypsin [lo] . Different sites 
available for the combination with trypsin and 
chymotrypsin were found in the molecule of soy bean 
trypsin inhibitor [ 111. Similarly, the enzymes may 
well employ other areas of contact and other amino 
acid residues for the binding. Since the bond between 
chymotrypsin and trypsin inhibitor has been found to 
be relatively weak, it is obvious that the bond between 
chymotrypsinogen and the inhibitor, if any, cannot 
even be perceived by our method. 
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